Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 122,975 |
|
|||||
| News | (2) | ||||||
| Day High | 0.7399 | Low High |
|||||
| Day Low | 0.7228 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Spruce Biosciences Inc | SPRB | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0111 | -1.50% | 0.73 | 11:59:50 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.7349 | 0.7228 | 0.7399 | 0.7411 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 537 | 122,975 | US$ 0.7289478 | US$ 89,642 | - | 0.67 - 5.95 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 12:00:09 | 1 | US$ 0.73 | USD |
Spruce Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 29.72M | 40.71M | - | 10.09M | -47.92M | -1.18 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Spruce Biosciences News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SPRB Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.6929 | 0.7466 | 0.67 | 0.7073802 | 360,982 | 0.0371 | 5.35% |
| 1 Month | 0.75 | 0.87 | 0.67 | 0.771436 | 474,249 | -0.02 | -2.67% |
| 3 Months | 5.15 | 5.53 | 0.67 | 0.9890424 | 1,394,343 | -4.42 | -85.83% |
| 6 Months | 1.52 | 5.95 | 0.67 | 1.57 | 829,465 | -0.79 | -51.97% |
| 1 Year | 2.34 | 5.95 | 0.67 | 1.61 | 464,550 | -1.61 | -68.80% |
| 3 Years | 13.38 | 13.87 | 0.67 | 3.28 | 659,373 | -12.65 | -94.54% |
| 5 Years | 17.00 | 35.60 | 0.67 | 3.68 | 555,277 | -16.27 | -95.71% |
Spruce Biosciences Description
| Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). |
